2842
Y. Cheng et al.
PAPER
6.81 (dd, J = 8.6, 2.6 Hz, 1 H), 6.78 (d, J = 2.4 Hz, 1 H), 4.36 (s, 2
H), 4.31 (s, 2 H), 4.05 (q, J = 7.0 Hz, 2 H), 2.92 (s, 3 H), 2.84 (s, 3
H), 1.43 (t, J = 7.0 Hz, 3 H).
13C NMR (125 MHz, CDCl3): = 152.1, 149.9, 145.6, 131.5, 129.9,
129.5, 128.3, 126.1, 118.6, 117.8, 116.4, 114.2, 64.5, 59.5, 59.1,
40.1, 39.6, 15.4.
1H NMR (500 MHz, CDCl3): = 7.45 (dd, J = 8.2, 1.5 Hz, 1 H),
7.35 (s, 1 H), 7.27–7.32 (m, 2 H), 6.96 (d, J = 8.3 Hz, 1 H), 6.77 (d,
J = 8.6 Hz, 1 H), 4.38 (s, 2 H), 4.33 (s, 2 H), 2.90 (s, 3 H), 2.87 (s,
3 H).
13C NMR (125 MHz, CDCl3): = 149.9, 149.4, 134.2, 131.4, 129.9,
129.1, 127.1, 126.5, 117.3, 116.4, 110.1, 58.9, 58.5, 39.5, 39.4.
MS (EI): m/z (%) = 531 (45), 562 (100) [M+], 563 (40).
MS (EI): m/z (%) = 131 (40), 601 (35), 630 (55) [M+], 632 (100),
634 (50).
HRMS (FT–MS): m/z calcd for C36H42N4O2: 562.3302; found:
562.3271.
HRMS (FT–MS): m/z calcd for C32H33N4Br2: 631.1066; found:
631.1059.
8,8 -Bis-5,11-dimethyl-5,6,11,12-tetrahydro-2-ethyldibenzo-
[b,f][1,5]diazocine (9d)
Yield: 38%; mp 273–274 °C.
8,8 -Bis-5,11-dimethyl-5,6,11,12-tetrahydro-4-methoxydiben-
zo[b,f][1,5]diazocine (9h)
Yield: 36%; mp 262–264 °C.
IR (KBr): 1607, 1498 cm–1.
1H NMR (500 MHz, CDCl3): = 7.46 (d, J = 8.1 Hz, 1 H), 7.40 (s,
1 H), 6.93 (d, J = 7.6 Hz, 2 H), 6.88 (d, J = 7.8 Hz, 1 H), 6.84 (d, J
= 7.1 Hz, 1 H), 4.55 (s, 2 H), 4.27 (s, 2 H), 3.92 (s, 3 H), 2.92 (s, 3
H), 2.61 (s, 3 H).
IR (KBr): 1610, 1509 cm–1.
1H NMR (500 MHz, CDCl3): = 7.45 (dd, J = 8.3, 2.0 Hz, 1 H),
7.37 (d, J = 1.7 Hz, 1 H), 7.07 (d, J = 8.1 Hz, 1 H), 7.00 (s, 1 H),
6.95 (d, J = 8.3 Hz, 1 H), 6.86 (d, J = 8.1 Hz, 1 H), 4.39 (s, 2 H),
4.36 (s, 2 H), 2.91 (s, 3 H), 2.88 (s, 3 H), 2.63 (q, J = 7.6 Hz, 2 H),
1.28 (t, J = 7.6 Hz, 3 H).
13C NMR (125 MHz, CDCl3): = 149.7, 149.1, 137.0, 134.1, 131.2,
129.8, 127.8, 127.6, 127.4, 126.2, 116.1, 116.0, 59.3, 59.1, 39.5,
39.0, 28.2, 16.0.
13C NMR (125 MHz, CDCl3): = 154.5, 148.9, 140.7, 134.1, 131.7,
130.7, 126.9, 126.2, 123.5, 121.8, 115.0, 111.9, 58.9, 58.6, 56.2,
39.0, 38.7.
MS (EI): m/z (%) = 160 (25), 234 (26), 499 (35), 530 (100) [M+],
MS (EI): m/z (%) = 162 (35), 503 (30), 534 (100) [M+], 535 (35).
531 (35).
HRMS (FT–MS): m/z calcd for C34H38N4O2: 534.2989; found:
HRMS (FT-MS): m/z calcd for C36H42N4: 530.3404; found:
534.2990.
530.3398.
8,8 -Bis-5,6,11,12-tetrahydro-4,5,11-trimethyldibenzo[b,f]-
[1,5]diazocine (9i)
Yield: 69%; mp 220–222 °C.
8,8 -Bis-5,11-dimethyl-5,6,11,12-tetrahydro-2-fluorodibenzo-
[b,f][1,5]diazocine (9e)
Yield: 53%, mp 274–276 °C.
IR (KBr): 1608, 1505 cm–1.
1H NMR (500 MHz, CDCl3): = 7.57 (br s, 1 H), 7.49 (s, 1 H), 7.10
(d, J = 6.6 Hz, 1 H), 7.02–7.04 (m, 3 H), 4.50 (s, 2 H), 4.45 (s, 2 H),
3.05 (s, 3 H), 2.99 (s, 3 H).
IR (KBr): 1607, 1499, 1477 cm–1.
1H NMR (500 MHz, CDCl3): = 7.45 (dd, J = 8.3, 1.9 Hz, 1 H),
7.41 (s, 1 H), 7.16 (d, J = 7.3 Hz, 1 H), 7.05 (br s, 1 H), 6.92–6.97
(m, 2 H), 4.54 (s, 2 H), 4.26 (s, 2 H), 2.96 (s, 3 H), 2.54 (s, 3 H), 2.39
(s, 3 H).
13C NMR (125 MHz, CDCl3): = 131.3, 129.9, 127.6, 126.3, 118.1,
117.9, 116.8, 116.1, 114.6, 114.4, 59.2, 58.7, 39.9, 39.6.
MS (EI): m/z (%) = 150 (40), 479 (35), 510 (100) [M+], 511 (30).
13C NMR (125 MHz, CDCl3): = 150.6, 149.1, 134.5, 131.0, 130.5,
130.1, 129.0, 128.5, 126.1, 122.2, 114.9, 113.4, 58.9, 58.6, 39.2,
39.1, 19.5.
MS (EI): m/z (%) = 146 (37), 502(100) [M+], 503 (35).
HRMS (FT–MS): m/z calcd for C32H32N4F2: 510.2589; found:
510.2577.
HRMS (FT–MS): m/z calcd for C34H38N4: 502.3091; found:
502.3088.
8,8 -Bis-5,11-dimethyl-5,6,11,12-tetrahydro-2-chlorodibenzo-
[b,f][1,5]diazocine (9f)
Yield: 81%; mp 279–281 °C.
8,8 -Bis-5,11-dimethyl-5,6,11,12-tetrahydro-4-chlorodibenzo-
[b,f][1,5]diazocine (9j)
Yield: 53%; mp 199–201 °C.
IR (KBr): 1609, 1497 cm–1.
IR (KBr): 1608, 1500 cm–1.
1H NMR (500 MHz, CDCl3): = 7.57 (d, J = 7.9 Hz, 1 H), 7.48 (s,
1 H), 7.29 (d, J = 8.2 Hz, 1 H), 7.26 (s, 1 H), 7.10 (d, J = 8.0 Hz, 1
H), 6.96 (d, J = 8.4 Hz, 1 H), 4.51 (s, 2 H), 4.46 (s, 2 H), 3.03 (s, 3
H), 3.00 (s, 3 H).
13C NMR (125 MHz, CDCl3): = 149.4, 131.4, 131.3, 130.0, 128.5,
128.2, 128.2, 127.0, 126.4, 122.6, 116.6, 116.1, 58.9, 58.5, 39.6,
39.5.
1H NMR (500 MHz, CDCl3): = 7.47 (dd, J = 8.2, 2.0 Hz, 1 H),
7.42 (s, 1 H), 7.36 (d, J = 7.9 Hz, 1 H), 7.10 (d, J = 7.6 Hz, 1 H),
6.90–6.97 (m, 2 H), 4.53 (s, 2 H), 4.25 (s, 2 H), 2.93 (s, 3 H), 2.64
(s, 3 H).
13C NMR (125 MHz, CDCl3): = 148.5, 143.1, 135.9, 131.3, 130.3,
129.7, 126.3, 122.7, 120.3, 115.3, 112.2, 58.8, 58.3, 39.1, 39.0.
MS (EI): m/z (%) = 166 (40), 511(35), 542 (100) [M+], 544 (65), 546
MS (EI): m/z (%) = 166 (40), 542 (100) [M+], 544 (75), 546 (20).
(18).
HRMS (FT–MS): m/z calcd for C32H32N4Cl2: 542.1998; found:
HRMS (FT–MS): m/z calcd for C32H32N4Cl2: 542.1998; found:
542.1988.
542.1986.
Acknowledgement
8,8 -Bis-5,11-dimethyl-5,6,11,12-tetrahydro-2-bromodiben-
zo[b,f][1,5]diazocine (9g)
Yield: 79%; mp 286–288 °C.
IR (KBr): 1607, 1589, 1499 cm–1.
This work was supported by the National Natural Science Founda-
tion of China. We thank to the analytical center of Beijing Normal
University for their help with the spectroscopic analyses.
Synthesis 2003, No. 18, 2839–2843 © Thieme Stuttgart · New York